Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02952586
Title Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Pfizer
Indications

head and neck squamous cell carcinoma

Therapies

Cisplatin

Avelumab + Cisplatin

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.